Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study

BACKGROUND: Appropriate and timely anticoagulant therapy with vitamin K antagonists (VKAs) or non-vitamin K oral antagonists (NOACs) is essential for stroke prevention in non-valvular atrial fibrillation (NVAF). Comparative data regarding effectiveness and safety for edoxaban vs phenprocoumon, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohmann, Christopher, Lutz, Magnus, Vignali, Sheila, Borchert, Kathrin, Seidel, Karolin, Braun, Sebastian, Baldus, Stephan, Näbauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251920/
https://www.ncbi.nlm.nih.gov/pubmed/35787710
http://dx.doi.org/10.1186/s12959-022-00395-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251920/
https://www.ncbi.nlm.nih.gov/pubmed/35787710
http://dx.doi.org/10.1186/s12959-022-00395-x

Ejemplares similares